Clinical Resources
Materials for Providers
Alphabetical by Title
Jynneos Intradermal (ID) Preparation and Administration Summary (CDC)
Jynneos Intradermal (ID) Standing Orders (CDC)
Jynneos Patient Screening Form (CDC)
Jynneos Subcutaneous (subcut) Preparation and Administration Summary (CDC)
Jynneos Subcutaneous (Subcut) Standing Orders (CDC)
Materials for Vaccine Recipients
Alphabetical by Title
Monkeypox Fast Facts (FDA)
Ask the Experts
CDC · FDA · State
ACIP Recommendations
Current Recommendations
Use of Jynneos (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — US, 2022
MMWR, May 27, 2022, Vol 71
Additional Federal Resources
- All current and archived ACIP Mpox recommendations
- ACIP Mpox recommendations at CDC
- CDC Mpox Information for Healthcare Professionals
- CDC Mpox [main page]
- Mpox Vaccination Basics (CDC)
- Interim Clinical Considerations for Use of JYNNEOS and ACAM2000 Vaccines during the 2022 U.S. Mpox Outbreak (CDC)
- Clinical Considerations for Treatment and Prophylaxis of Mpox Infection in People Who are Immunocompromised (vaccination section) (CDC)
- Clinical Considerations for Mpox in Children and Adolescents (vaccines section) (CDC)
- Clinical Considerations for Mpox in People Who are Pregnant or Breastfeeding (vaccines section) (CDC)
- Video: Subcutaneous (SC or Subcut) Injection: Administration (CDC)
- Animated video: How to administer a Jynneos vaccine intradermally (CDC)
- Mpox Vaccination Basics for Healthcare Professionals (CDC)
- Monkeypox Vaccine Locator (CDC)
- Vaccine Effectiveness and Safety (CDC)
- Communication Resources (CDC)
- Vaccine Storage and Handling Toolkit (CDC): Mpox vaccine information found in addendum
- Healthcare Provider Letter on acceptable vax storage temps (June 2022) (Bavarian Nordic)
- ASPR/CDC Mpox Vaccination Operational Planning Guide (ASPR, CDC)
- General Best Practice Guidelines for Immunization
Vaccine Information Statements
Smallpox/monkeypox VIS
Updated: November 14, 2022
CDC Recommended Schedules
2024 Child and Adolescent Immunization Schedule
- Page count: 15
- Color
- Size: 8.5 ” x 11″
2024 Adult Immunization Schedule
- Page count: 13
- Color
- Size: 8.5 ” x 11″
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2023
Source: The Morbidity and Mortality Weekly Report (MMWR) series prepared by CDC.
The next MMWR publication of the schedule will occur in January 2024
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2023
Source: The Morbidity and Mortality Weekly Report (MMWR) series prepared by CDC.
The next MMWR publication of the schedule will occur in January 2024
FDA Package Inserts & EUAs
Smallpox & Mpox: Jynneos Package Insert
Bavarian Nordic A/S
Smallpox & Mpox: EUA Full Prescribing Information – Jynneos
Jynneos
Partner Resources
Governmental
ASPRʼs Strategic National Stockpile (SNS) deploys vaccines and treatments to jurisdictions across the United States to support communities affected by mpox.
Non-Governmental
The Association of Immunization Managersʼ directory lists the program manager, contact information, and website for each location.
Manufacturers
Product: Smallpox and Monkeypox (Jynneos)
